The project to decode the human genome has been completed two years ahead of schedule, but scientists have warned against …
Abbott Labs recorded a 6% drop in profits for the first quarter of 2003 following heavy spending on the launch …
GlaxoSmithKline has suffered a set back in its bid to see off early US generic competition for antibiotic Augmentin, one …
European MPs have voted to ban the use of human cloning and embryonic stem cells for research purposes.The vote could …
NHS professionals are to be given new clinical guidelines in two important areas of mental health as part of NICE's …
The British Medical Journal has accused the pharmaceutical industry of creating bogus disease areas in order to sell treatments.The respected …
AstraZeneca's new anticoagulant Exanta has shown to be more effective than warfarin in preventing stroke in patients suffering from arrhythmia.Exanta …
Price competition is not a major factor in the UK prescription pharma market, according to a Department of Health report.The …
Hospitals built under the private finance initiative are suffering from financial problems, bed shortages and poor design, according to a …
Galen faces a legal challenge in the US over the patent rights to a product it bought only last month.The …
Schering-Plough has admitted that it underestimated the effect that Claritin switching to an over-the-counter product would have on its profits.The …
Deep divisions within the Labour party over foundation hospitals have been further exposed in the House of Commons.More than 100 …